My son Adam is scheduled for Ocrevus treatment at Stanford Hospital April 3 & 17. I’m not certain I should take him out in public for his treatment due to the Coronavirus. I’m feeling uncomfortable not knowing if we should go or not. Adam is wheelchair bound. Please advise.
I can truly empathize with how difficult this decision is. I have Secondary Progressive MS and am on a similar infusion. I have been advised not to proceed with treatment due to Coronavirus. I want to emphasize that each individual’s MS is different. My physician made a decision based on my case.
I see Adam is scheduled two weeks apart. That tells me this is his first infusion of Ocrevus. I suggest speaking with his neurologist to discuss your concerns. S/he can best guide you. as to what would be in Adam’s best interest.
Thank you so much for reaching out. We wish both you and Adam the very best.
Adding to what Jenn has written, the MS International Federation has issued guidelines regarding treatment with the various disease-modifying medications in the current situation. Continuing treatment really depends on the way in which the medication effects the immune system. Here’s part of what the Federation’s website says:
People with MS who are currently taking alemtuzumab, cladribine, ocrelizumab, rituximab, fingolimod, dimethyl fumarate, teriflunomide or siponimod and are living in a community with a COVID-19 outbreak should isolate as much as possible to reduce their risk of infection.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.